These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25420716)

  • 41. Experiences with Yasmin: the acceptability of a novel oral contraceptive and its effect on well-being.
    Mansour D
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():35-41; discussion 42-3. PubMed ID: 12659405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined estrogen-progestin oral contraceptives and female sexuality: an updated review.
    Krapf JM; Goldstein AT
    Sex Med Rev; 2024 Jun; 12(3):307-320. PubMed ID: 38515302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Women's sexuality, well-being, and the menstrual cycle: methodological issues and their interrelationships.
    Brown SG; Calibuso MJ; Roedl AL
    Arch Sex Behav; 2011 Aug; 40(4):755-65. PubMed ID: 20464468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures.
    Huang SC; Chen HC; Chen RJ; Hsieh CY; Wei PY; Ouyang PC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):646-53. PubMed ID: 6699130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral contraceptives, androgens, and the sexuality of young women: II. The role of androgens.
    Bancroft J; Sherwin BB; Alexander GM; Davidson DW; Walker A
    Arch Sex Behav; 1991 Apr; 20(2):121-35. PubMed ID: 2064538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The influence of combined oral contraceptives on female sexual desire: a systematic review.
    Pastor Z; Holla K; Chmel R
    Eur J Contracept Reprod Health Care; 2013 Feb; 18(1):27-43. PubMed ID: 23320933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Choosing contraception for adolescents].
    Wemeau-jacquemont C
    NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The shady side of contraception].
    Lesage-desrousseaux E; Delcroix M; Coliche D; Pigache IP
    Contracept Fertil Sex (Paris); 1985 Apr; 13(4):697-700. PubMed ID: 12340146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical and biological justifications for the use of Triella].
    McGuire JL; Pasquale SA; Castaigne JP
    Rev Fr Gynecol Obstet; 1986 Dec; 81(12):731-6. PubMed ID: 3823727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms.
    Apter D; Borsos A; Baumgärtner W; Melis GB; Vexiau-Robert D; Colligs-Hakert A; Palmer M; Kelly S
    Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):37-51. PubMed ID: 12725674
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices.
    Martin-Loeches M; Ortí RM; Monfort M; Ortega E; Rius J
    Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):129-34. PubMed ID: 14667322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
    Dieben TO; van Beek A; Coelingh Bennink HJ
    Arzneimittelforschung; 1991 Sep; 41(9):996-8. PubMed ID: 1839126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical study of a low-dose contraceptive--Femodene].
    Rachev E; Damianov L; Dukovski A; Katsarova M
    Akush Ginekol (Sofiia); 1995; 34(3):71-3. PubMed ID: 8787249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium.
    Franceschini SA; Vieira CS; Martins WP; França JB; Ferriani RA
    Contraception; 2013 Jun; 87(6):766-72. PubMed ID: 23102798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO).
    Cagnacci A; Bastianelli C; Neri M; Cianci A; Benedetto C; Calanni L; Vignali M; De Leo V; Cicinelli E; Borrelli G; Volpe A;
    Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):393-399. PubMed ID: 30465698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
    Merz M; Kroll R; Lynen R; Bangerter K
    Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. YAZ and the novel progestin drospirenone.
    Mishell DR
    J Reprod Med; 2008 Sep; 53(9 Suppl):721-8. PubMed ID: 18980044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Implications of cycle length immediately after discontinuation of combined oral contraceptives on use of the Standard Days Method.
    Arévalo M; Sinai I; Olivotti B; Bahamondes L
    Int J Gynaecol Obstet; 2010 Oct; 111(1):78-81. PubMed ID: 20650457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conducting high-quality research on the psychological impact of oral contraceptive use.
    Cobey KD; Buunk AP
    Contraception; 2012 Oct; 86(4):330-1. PubMed ID: 22386231
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
    Kriplani A; Periyasamy AJ; Agarwal N; Kulshrestha V; Kumar A; Ammini AC
    Contraception; 2010 Aug; 82(2):139-46. PubMed ID: 20654754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.